Big pharma joins hunt for coronavirus vaccine as outbreak escalatesBig pharma has joined the hunt for a vaccine for the deadly coronavirus outbreak that is beginning to Share XBig pharma joins hunt for coronavirus vaccine as outbreak escalateshttps://pharmaphorum.com/news/big-pharma-joins-hunt-for-coronavirus-vaccine-as-outbreak-escalates/
Digital interventions could help behaviour change, says NICEThe UK’s health watchdog has said health professionals can consider digital and mobile interventions as a supplement to Share XDigital interventions could help behaviour change, says NICEhttps://pharmaphorum.com/news/digital-interventions-could-help-behaviour-change-says-nice/
Neil Flash joins med comms group Lucid as chief commercial officerLucid Group has appointed Neil Flash to the newly-created role of chief commercial officer. He will also serve Share XNeil Flash joins med comms group Lucid as chief commercial officerhttps://pharmaphorum.com/news/lucid-group-neil-flash/
Babylon Health to create city-wide digital health service with UK hospitalBabylon Health, the company behind the GP at Hand phone app being piloted in the NHS, has partnered Share XBabylon Health to create city-wide digital health service with UK hospitalhttps://pharmaphorum.com/news/babylon-health-to-create-city-wide-digital-health-service-with-uk-hospital/
PatchAi launches virtual assistant for clinical trial patientsThe Italian startup PatchAi has launched an empathic virtual assistant designed to help patients taking part in the Share XPatchAi launches virtual assistant for clinical trial patientshttps://pharmaphorum.com/news/patchai-launches-virtual-assistant-for-clinical-trial-patients/
Roche edges closer to SMA market as risdiplam hits target in trial in babiesRoche is to begin discussions with regulators about new data from risdiplam, its developmental oral treatment for the Share XRoche edges closer to SMA market as risdiplam hits target in trial in babieshttps://pharmaphorum.com/news/roche-sma-risdiplam-babies/
Bayer gets Japanese approval for prostate cancer drug NubeqaBayer and Orion’s prostate cancer drug Nubeqa (darolutamide) is gaining steam in its battle against rivals from J&J Share XBayer gets Japanese approval for prostate cancer drug Nubeqahttps://pharmaphorum.com/news/bayer-gets-japanese-approval-for-prostate-cancer-drug-nubeqa/
Race is on to find coronavirus vaccine as outbreak escalatesThe race is on to find a vaccine for the coronavirus outbreak that has put an entire Chinese Share XRace is on to find coronavirus vaccine as outbreak escalateshttps://pharmaphorum.com/news/race-is-on-to-find-coronavirus-vaccine-as-outbreak-escalates/
Poor data hindering machine learning in drug R&DA lack of high-quality data is hindering use of machine learning in drug development, according to a new Share XPoor data hindering machine learning in drug R&Dhttps://pharmaphorum.com/news/poor-data-hindering-machine-learning-in-drug-rd/
